Resultats de la cerca - Chee‐Keong Toh
- Mostrar 1 - 11 resultats de 11
-
1
-
2
-
3
-
4
EGFR Mutation Subtypes Influence Survival Outcomes following First-Line Gefitinib Therapy in Advanced Asian NSCLC Patients per Natalia Sutiman, Shao Weng Tan, Eng Huat Tan, Wan‐Teck Lim, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Mei‐Kim Ang, Wan Ling Tan, Chee‐Keong Toh, Balram Chowbay
Publicat 2016Artigo -
5
Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity per Chee‐Keong Toh, Fei Gao, Wan‐Teck Lim, Swan‐Swan Leong, Kam-Weng Fong, Swee‐Peng Yap, Anne Ann Ling Hsu, Philip Eng, Heng‐Nung Koong, Thirugnanam Agasthian, Eng-Huat Tan
Publicat 2006Artigo -
6
A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma per Wan‐Teck Lim, Quan‐Sing Ng, Percy Ivy, Swan-Swan Leong, Onkar Singh, Balram Chowbay, Fei Gao, Choon Hua Thng, Boon-Cher Goh, Daniel Shao-Weng Tan, Tong San Koh, Chee‐Keong Toh, Eng-Huat Tan
Publicat 2011Artigo -
7
Dual modulation of MCL-1 and mTOR determines the response to sunitinib per Mohamed Elgendy, Amal Kamal Abdel‐Aziz, Salvatore Lorenzo Renne, Viviana Bornaghi, Giuseppe Procopio, Maurizio Colecchia, Ravindran Kanesvaran, Chee‐Keong Toh, Daniela Bossi, Isabella Pallavicini, Jose Luis Pérez‐Gracia, María D. Lozano, Valeria Giandomenico, Ciro Mercurio, Luisa Lanfrancone, Nicola Fazio, Franco Nolè, Bin Tean Teh, Giuseppe Renne, Saverio Minucci
Publicat 2016Artigo -
8
Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer per Stephanie P.L. Saw, Siqin Zhou, Jianbin Chen, Gillianne Lai, Mei‐Kim Ang, Kevin Lee Min Chua, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Wan Ling Tan, Tanujaa Rajasekaran, Wan‐Teck Lim, Aaron C. Tan, Kam Weng Fong, Angela Takano, Xin Cheng, Kiat Hon Lim, Tina Koh, Boon‐Hean Ong, Eng Huat Tan, Chee‐Keong Toh, Anders J. Skanderup, Sze Huey Tan, Daniel Shao-Weng Tan
Publicat 2021Artigo -
9
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH) per Solange Peters, Scott Gettinger, Melissa L. Johnson, Pasi A. Jänne, Marina Chiara Garassino, Daniel C. Christoph, Chee‐Keong Toh, Naiyer A. Rizvi, Jamie E. Chaft, Enric Carcereny, Jyoti D. Patel, Laura Q.M. Chow, Marianna Koczywas, Cheryl Ho, Martin Früh, Michel M. van den Heuvel, J. Rothenstein, Martin Reck, Luis Paz‐Ares, Frances A. Shepherd, Takayasu Kurata, Zhengrong Li, Jiaheng Qiu, Marcin Kowanetz, Simonetta Mocci, Geetha Shankar, Alan Sandler, Enriqueta Felip
Publicat 2017Artigo -
10
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing per Rahul Nahar, Weiwei Zhai, Tong Zhang, Angela Takano, Alexis Jiaying Khng, Yin Yeng Lee, Xingliang Liu, Chong Hee Lim, Tina Koh, Zaw Win Aung, Tony Kiat Hon Lim, Lavanya Veeravalli, Ju Yuan, Audrey S.M. Teo, Cheryl Xueli Chan, Huay Mei Poh, I-Ly Joanna Chua, Audrey Ann Liew, Dawn Lau, Xue Lin Kwang, Chee‐Keong Toh, Wan‐Teck Lim, Bing Lim, Wai Leong Tam, Eng-Huat Tan, Axel M. Hillmer, Daniel Shao-Weng Tan
Publicat 2018Artigo -
11
Genomic landscape of lung adenocarcinoma in East Asians per Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Lidyana Bte Amer, Faranak Ghazi Sherbaf, Chu Quan Tan, Jacob J.S. Alvarez, Bingxin Lu, Jia Qi Lim, Angela Takano, Rahul Nahar, Yin Yeng Lee, Cheryl Zi Jin Phua, Khi Pin Chua, Lisda Suteja, Pauline Jieqi Chen, Mei Mei Chang, Tina Puay Theng Koh, Boon‐Hean Ong, Devanand Anantham, Anne Ann Ling Hsu, Apoorva Gogna, Chow Wei Too, Zaw Win Aung, Yi Fei Lee, Lanying Wang, Tony Kiat Hon Lim, Andreas Wilm, Poh Sum D. Choi, Poh Yong Ng, Chee‐Keong Toh, Wan‐Teck Lim, Siming Ma, Bing Lim, Jin Liu, Wai Leong Tam, Anders J. Skanderup, Joe Yeong, Eng-Huat Tan, Caretha L. Creasy, Daniel S.W. Tan, Axel M. Hillmer, Weiwei Zhai
Publicat 2020Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Cancer
Oncology
Chemotherapy
Gastroenterology
Lung cancer
Biology
Adenocarcinoma
Cancer research
Gene
Genetics
Nasopharyngeal carcinoma
Radiation therapy
Surgery
Chemotherapy regimen
Clinical endpoint
Clinical trial
Cohort
Epidermal growth factor receptor
Genome
Mutation
Paclitaxel
Phases of clinical research
Progressive disease
Proportional hazards model
Regimen
Sunitinib
Tyrosine-kinase inhibitor
Adjuvant therapy